A Novel Molecular Target in EGFR-Mutant Non-Small Cell Lung Cancer Treated With a Combination of Osimertinib and Pemetrexed
Natsuki Takano(Nippon Medical School), Akihiko Gemma(Nippon Medical School)
Cited by 0
Related Papers
MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting <i>MAGI2</i> in Lung Adenocarcinoma Cells
|Molecular Cancer Therapeutics|2013|186
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells
|International Journal of Oncology|2012|169
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
|International Journal of Oncology|2016|83